Autism Disorder & Treatment Market to Grow at a Decent Pace of 4.3% till 2023 | Pfizer Inc., Eli Lilly and Company, Allergan, Merck & CO Inc., etc | MRFR

Autism Disorder & Treatment Market to Grow at a Decent Pace of 4.3% till 2023 | Pfizer Inc., Eli Lilly and Company, Allergan, Merck & CO Inc., etc | MRFR

“Autism Disorder & Treatment Market”
The report titled Global Autism Disorder & Treatment Market 2018 Research Report implements an exhaustive study on Market Research Future. This Report Cover market size, growth rate, opportunities, market Dynamics and Factor Analysis.

Autism Disorder & Treatment Market Global Players:

The Global Autism Disorder & Treatment Market comprises a host of key players. This includes names like Novartis AG, Pfizer Inc., Eli Lilly, and Company, Consern Pharma Private Limited, Johnson & Johnson Services, Inc. Heptares Therapeutics Limited, Coronis Partners Ltd., Teva Pharmaceutical Industries Ltd., Intra-Cellular Therapies Inc., Saniona AB, Bristol-Myers Squibb and Otsuka Holdings Co., Ltd., Merck & CO Inc., Allergan, Curemark LLC, and others.

Market Overview

The Global Autism Disorder & Treatment Market was analyzed by Market Research Future (MRFR) and it was projected that a decent CAGR of 4.3% will be attained by the market over the forecast period of 2017 to 2023. The valuation of the autism disorder & treatment market was further stated to surpass its previous valuation by 2023.

Request Free Sample Copy at https://www.marketresearchfuture.com/sample_request/1605

The various major effects of autism on social skills, speech, and nonverbal communication are some of the leading areas that are being focused upon when it comes to the treatment and medications of the same. The global market for autism disorder and treatment has been reported to be one of the rapidly growing industries due to increasing awareness about autism among patients and increasing prevalence of autism and Pervasive Developmental Disorder (PDD).

Autism disorder and treatment is said to be one of the leading markets in the healthcare industry due to the favorable initiatives taken by the government of various different countries and expected approvals from the Food and Drug Association (FDA) for various off-label treatment therapies. However, the market can face some challenges in growth due to weak pipeline of drugs for autism disorder and lack of awareness concerning etiology and pathophysiology of ASD.

Market Segmentation

The Global Autism Disorder & Treatment Market has been segmented in terms of type, end-user, and components.

By type, the market breaks down into Pervasive Developmental Disorder, Asperger Syndrome, and others. The pervasive developmental disorder segment leads the global market and is projected to grow over the forecast period at a CAGR of 4.73%.

By treatment type, the market segments into oxytocin therapy, ABA (applied behavioral analysis), chelation therapy, hyperbaric oxygen therapy, and others. The applied behavioral analysis segment leads the market standings and is projected to gain a CAGR of 4.82% during the forecast period.

By drug, the market segments into SSRIs, anti-psychotic anti-convulsant, stimulants, and others. Anti-psychotics segment is further broken down into Abilify (aripiprazole) and Risperidone. The anti-psychotic segment enjoys the largest share of the global market and is reported to grow over the forecast period at an annual rate of 3.95%.

Regional Analysis

The global autism disorder & treatment market is geographically distributed across the following key regions: Asia Pacific, North America, Europe, and the Middle East and Africa. Americas hold the highest market share in autism disorder & treatment and is closely followed by Europe. In Americas, North America accounted for the largest market share percentage due to the rising screening of autism cases in the region. Add to this, the approval as well as the expected launch of the atypical anti-psychotic such as Namenda and Latuda is anticipated to garner increased sales in the U.S. during the post-approval period.

Asia Pacific is projected by MRFR to be the fastest growing regional market in the coming years. While the Middle East & Africa region is anticipated to register slow and steady growth rate over the forecast period. As per the epidemiological studies that were conducted over the past 50 years or so, it was suggested that the prevalence of ASD is spreading globally at a rapid pace. Some of the key factors driving the increasing prevalence of the same are expansion of diagnostic criteria, improved awareness, better diagnostic tools and improved reporting procedure.

Access Full Report at https://www.marketresearchfuture.com/reports/autism-disorder-and-treatment-market-1605

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/autism-disorder-and-treatment-market-1605